Study examines treatment options for women with recurrent ovarian cancer
Share

New research indicates that for women with advanced epithelial ovarian cancer whose cancer has relapsed after surgery, a second surgery is worth considering. The population-based registry study confirms the results suggested by a recent randomized trial.

In the Acta Obstetricia et Gynecologica Scandinavica study, secondary surgery delayed a new recurrence for 2 years and resulted in at least 6 years median overall survival.

“Treatment for ovarian cancer is centralized to only a few hospitals in Norway. The favourable results may encourage other countries to adopt this model in order to treat more patients with secondary surgery at first recurrence,” said lead author Dr. Witold Szczesny, of the Cancer Registry of Norway.

###

New research indicates that for women with advanced epithelial ovarian cancer whose cancer has relapsed after surgery, a second surgery is worth considering. The population-based registry study confirms the results suggested by a recent randomized trial.

In the Acta Obstetricia et Gynecologica Scandinavica study, secondary surgery delayed a new recurrence for 2 years and resulted in at least 6 years median overall survival.

Acta Obstetricia et Gynecologica Scandinavica

“Treatment for ovarian cancer is centralized to only a few hospitals in Norway. The favourable results may encourage other countries to adopt

read more...


Article originally posted at
www.eurekalert.org

Click here for the full story


CategoryAggregator News

© 2017 - LIFE EXTENSION ADVOCACY FOUNDATION
Privacy Policy / Terms Of Use

Powered by MMD